UTILIZING CENTRALIZED BIOREPOSITORY SAMPLES FOR BIOMARKERS OF CYSTIC FIBROSIS LUNG DISEASE SEVERITY

BACKGROUND: Circulating biomarkers reflective of lung disease activity and severity have the potential to improve patient care and accelerate drug development in CF. The objective of this study was to leverage banked specimens to test the hypothesis that blood-based biomarkers discriminate CF childr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cyst Fibros
Autors principals: Sagel, Scott D., Wagner, Brandie D., Ziady, Assem, Kelley, Tom, Clancy, John P., Narvaez-Rivas, Monica, Pilewski, Joseph, Joseloff, Elizabeth, Sha, Wei, Zelnick, Leila, Setchell, Kenneth D. R., Heltshe, Sonya L., Muhlebach, Marianne S.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305052/
https://ncbi.nlm.nih.gov/pubmed/31870630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2019.12.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars